Associate Sponsors

Co-sponsor

Sales decline 59.06% to Rs 141.96 crore

Net loss of Sharon Bio-Medicine reported to Rs 82.43 crore in the quarter ended June 2015 as against net profit of Rs 20.35 crore during the previous quarter ended June 2014. Sales declined 59.06% to Rs 141.96 crore in the quarter ended June 2015 as against Rs 346.76 crore during the previous quarter ended June 2014.

For the full year,net loss reported to Rs 225.86 crore in the year ended June 2015 as against net profit of Rs 69.62 crore during the previous year ended June 2014. Sales declined 36.52% to Rs 833.95 crore in the year ended June 2015 as against Rs 1313.77 crore during the previous year ended June 2014.

ParticularsQuarter EndedYear EndedJun. 2015Jun. 2014% Var.Jun. 2015Jun. 2014% Var.Sales141.96346.76 -59 833.951313.77 -37 OPM %3.7112.77 --4.1111.95 - PBDT-43.3031.24 PL -125.30105.60 PL PBT-48.8428.25 PL -144.5690.25 PL NP-82.4320.35 PL -225.8669.62 PL

Powered by Capital Market - Live News

More From This Section

First Published: Sep 01 2015 | 3:22 PM IST

Next Story